231 related articles for article (PubMed ID: 7693430)
21. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
Titova NV; Katunina EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
[No Abstract] [Full Text] [Related]
22. Treatment of Parkinson's disease: problems with a progressing disease.
Rinne UK
J Neural Transm; 1981; 51(1-2):161-74. PubMed ID: 7264627
[TBL] [Abstract][Full Text] [Related]
23. New pharmacotherapy for Parkinson's disease.
Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
[TBL] [Abstract][Full Text] [Related]
24. Clinical usefulness of apomorphine in movement disorders.
Colosimo C; Merello M; Albanese A
Clin Neuropharmacol; 1994 Jun; 17(3):243-59. PubMed ID: 9316670
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?].
Ceballos-Baumann A
MMW Fortschr Med; 2003 May; 145 Suppl 2():99-102. PubMed ID: 14579497
[TBL] [Abstract][Full Text] [Related]
26. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
27. Subcutaneous apomorphine in parkinsonian on-off oscillations.
Stibe CM; Lees AJ; Kempster PA; Stern GM
Lancet; 1988 Feb; 1(8582):403-6. PubMed ID: 2893200
[TBL] [Abstract][Full Text] [Related]
28. Management of levodopa failures: the use of dopamine agonists.
Lieberman AN; Gopinathan G; Neophytides A; Goldstein M
Clin Neuropharmacol; 1986; 9 Suppl 2():S9-21. PubMed ID: 3297319
[TBL] [Abstract][Full Text] [Related]
29. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
30. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Kim JY; Chung EJ; Park SW; Lee WY
Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
[TBL] [Abstract][Full Text] [Related]
31. Apomorphine for motor fluctuations and freezing in Parkinson's disease.
Corboy DL; Wagner ML; Sage JI
Ann Pharmacother; 1995 Mar; 29(3):282-8. PubMed ID: 7606075
[TBL] [Abstract][Full Text] [Related]
32. Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.
Langtry HD; Clissold SP
Drugs; 1990 Mar; 39(3):491-506. PubMed ID: 2184010
[TBL] [Abstract][Full Text] [Related]
33. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.
Antonini A; Poewe W
Lancet Neurol; 2007 Sep; 6(9):826-9. PubMed ID: 17706566
[TBL] [Abstract][Full Text] [Related]
34. Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response.
Maggio R; Barbier P; Corsini GU
J Neural Transm Suppl; 1995; 45():133-6. PubMed ID: 8748618
[TBL] [Abstract][Full Text] [Related]
35. Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.
Perez-Lloret S; Rascol O
CNS Drugs; 2016 Aug; 30(8):703-17. PubMed ID: 27344665
[TBL] [Abstract][Full Text] [Related]
36. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
Zoldan J; Merims D; Kuritzky A; Ziv I; Melamed E
Harefuah; 1999 Nov; 137(10):444-6, 512, 511. PubMed ID: 10959339
[TBL] [Abstract][Full Text] [Related]
37. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
38. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
39. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Grosset K; Needleman F; Macphee G; Grosset D
Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
[TBL] [Abstract][Full Text] [Related]
40. Dopamine agonists in Parkinson's disease: a look at apomorphine.
Lees AJ
Fundam Clin Pharmacol; 1993; 7(3-4):121-8. PubMed ID: 8500783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
